<DOC>
	<DOCNO>NCT00954122</DOCNO>
	<brief_summary>The purpose study determine whether treatment quetiapine XR ( Seroquel XR ) tablets 3 week improve agitation acute psychosis .</brief_summary>
	<brief_title>Efficacy Safety SEROQUEL Extended Release ( XR ) Acute Schizophrenia</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<criteria>Requirement treatment acute episode schizophrenia ( accord DSMIV diagnostic criterion ) PANSS total score Â³ 75 CGI &gt; 4 Any DSMIV ( Diagnostic Statistical Manual Mental Disorders 4th Edition ) Axis I disorder define inclusion criterion Patients , opinion investigator , pose imminent risk suicide danger self others Substance alcohol dependence enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>January 2013</verification_date>
	<keyword>Acute schizophrenia</keyword>
</DOC>